No. 23-267

Marilyn Williams v. Boehringer Ingelheim Pharmaceuticals, Inc., et al.

Lower Court: Eleventh Circuit
Docketed: 2023-09-20
Status: Denied
Type: Paid
Response RequestedResponse WaivedRelisted (2) Experienced Counsel
Tags: appellate-jurisdiction circuit-split civil-procedure final-decision interlocutory-ruling rule-41 rule-41(a) voluntary-dismissal
Key Terms:
JusticiabilityDoctri Jurisdiction
Latest Conference: 2024-02-16 (distributed 2 times)
Question Presented (from Petition)

Does an interlocutory ruling that dismisses some (but not all) of a plaintiff's claims with prejudice become an appealable "final decision" if the plaintiff voluntarily dismisses her action under Rule 41(a)?

Question Presented (AI Summary)

Does an interlocutory ruling that dismisses some (but not all) of a plaintiff's claims with prejudice become an appealable 'final decision' if the plaintiff voluntarily dismisses her action under Rule 41(a)?

Docket Entries

2024-02-20
Petition DENIED.
2024-01-10
DISTRIBUTED for Conference of 2/16/2024.
2024-01-04
2023-12-21
Brief of respondents Boehringer Ingelheim Pharmaceuticals, Inc. et al. in opposition filed.
2023-11-14
Motion to extend the time to file a response is granted and the time is extended to and including December 22, 2023.
2023-11-13
Motion to extend the time to file a response from December 6, 2023 to December 22, 2023, submitted to The Clerk.
2023-11-06
Response Requested. (Due December 6, 2023)
2023-11-01
DISTRIBUTED for Conference of 11/17/2023.
2023-10-16
Waiver of right of respondents Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corp. to respond filed.
2023-09-15
Petition for a writ of certiorari filed. (Response due October 20, 2023)
2023-07-27
Application (23A79) granted by Justice Thomas extending the time to file until September 15, 2023.
2023-07-25
Application (23A79) to extend the time to file a petition for a writ of certiorari from August 16, 2023 to October 15, 2023, submitted to Justice Thomas.

Attorneys

Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corp.
Paul Alessio MezzinaKing & Spalding LLP, Respondent
Marilyn Williams
Ashley Conrad KellerKeller Postman LLC, Petitioner
Jonathan F. MitchellMitchell Law PLLC, Petitioner